Skip to main content
SpringerLink
Log in

Remifentanil/rocuronium-bromide

Anaphylaxis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Suzuki M, et al. Skin Testing to Identify Safe Drugs for Patients with Rocuronium-Induced Anaphylaxis. Case Reports in Anesthesiology 2020: 2020. Available from: URL: https://www.hindawi.com/journals/cria/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Remifentanil/rocuronium-bromide. Reactions Weekly 1920, 417 (2022). https://doi.org/10.1007/s40278-022-21954-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-21954-9

Search

Navigation